targeted cellular responses
CytoComm™ for Cardiology
CytoComm™ is being designed to allow wireless monitoring in at-risk cardiac patients. CytoComm™ will provide real-time patient information, allowing physicians to take preemptive and potentially life-saving action before a significant event (i.e. heart attack) occurs.
Cardiovascular disease is expensive, debilitating, and deadly. Before heart failure ever occurs, the human body produces biomarkers – BNP, epinephrine, troponin, etc. – that signal an event is likely to occur. Current monitoring methods to measure these biomarkers are unfortunately hampered by a lack of effective and personalized in vivo tools. Using living cells to collect rich and physiologically relevant information, CytoComm™ is being built to notify physicians of increased precursor levels and allow for a proactive course of treatment.